MolecularMD Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MolecularMD Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0129
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging strategies, clinical trial design, regulatory planning, analytical and clinical assay validation, fda submission services, and custom clinical gmp kit manufacturing. Its technologies comprise next generation sequencing, droplet digital pcr, qpcr, rt-qpcr, allele-specific pcr, sanger sequencing, capillary electrophoresis fragment analysis, immunohistochemistry, hematoxylin and eosin staining, and digital imaging. MMD’s clinical trails services include centralized clinical testing, clinical trial assay and IVD development, advanced diagnostics, and manufacturing commercialization. The company serves the biopharma’s needs for clinical trial assays and clinical trial services. It operates offices in Oregon and Massachusetts, the US. MMD is headquartered in Portland, Oregon, the US.

MolecularMD Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MolecularMD Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MolecularMD Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MolecularMD Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MolecularMD Corp, Medical Equipment, Deal Details 11
Venture Financing 11
MolecularMD Raises USD0.5 Million in Venture Financing 11
MolecularMD Raises US$2.5 Million In Venture Financing 12
MolecularMD Raises US$6 Million In Series B Financing 13
Partnerships 14
MolecularMD Enters Into Licensing Agreement With Broad Institute And Dana-Farber Cancer Institute 14
MolecularMD Enters Into Licensing Agreement With Washington University And Translational Genomics Research Institute 15
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 16
MolecularMD and Genoptix Enter into Agreement 18
MolecularMD Enters into Agreement with Indica Labs 19
Asterand Bioscience Enters into Partnership with MolecularMD 20
MolecularMD Enters into Agreement with Illumina 21
Definiens Partners with MolecularMD 22
MolecularMD Enters Into Agreement With Novartis To Develop Companion Diagnostic Test For Chronic Myelogenous Leukemia 23
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 24
MolecularMD Corp – Key Competitors 25
MolecularMD Corp – Key Employees 26
MolecularMD Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Legal and Regulatory 28
Jun 01, 2017: MolecularMD achieves status as an ArcherDX Certified Service Provider and expands offering of novel NGS chemistries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
MolecularMD Corp, Medical Equipment, Key Facts 2
MolecularMD Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MolecularMD Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MolecularMD Corp, Deals By Market, 2012 to YTD 2018 8
MolecularMD Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MolecularMD Raises USD0.5 Million in Venture Financing 11
MolecularMD Raises US$2.5 Million In Venture Financing 12
MolecularMD Raises US$6 Million In Series B Financing 13
MolecularMD Enters Into Licensing Agreement With Broad Institute And Dana-Farber Cancer Institute 14
MolecularMD Enters Into Licensing Agreement With Washington University And Translational Genomics Research Institute 15
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 16
MolecularMD and Genoptix Enter into Agreement 18
MolecularMD Enters into Agreement with Indica Labs 19
Asterand Bioscience Enters into Partnership with MolecularMD 20
MolecularMD Enters into Agreement with Illumina 21
Definiens Partners with MolecularMD 22
MolecularMD Enters Into Agreement With Novartis To Develop Companion Diagnostic Test For Chronic Myelogenous Leukemia 23
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 24
MolecularMD Corp, Key Competitors 25
MolecularMD Corp, Key Employees 26
MolecularMD Corp, Other Locations 27

List of Figures
MolecularMD Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MolecularMD Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MolecularMD Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MolecularMD Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Braile Biomedica Ltda:製品パイプライン分析
    Summary Braile Biomedica Ltda (Braile Biomedica) is a medical device company that develops biological, cardiovascular, electromechanical, endovascular, and oncology products. The company’s cardiovascular products comprise wirewound arterial cannula, anterograde cardioplegia cannula, wirewound venous …
  • Ryanair Holdings plc:企業の戦略・SWOT・財務情報
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China Mobile Ltd (941):企業の財務・戦略的SWOT分析
    China Mobile Ltd (941) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Agricultural Bank of China Ltd:企業の戦略・SWOT・財務情報
    Agricultural Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Agricultural Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cepheid:企業の戦略的SWOT分析
    Cepheid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • HUYA Bioscience International LLC-製薬・医療分野:企業M&A・提携分析
    Summary HUYA Bioscience International LLC (HUYA) is a developer of early and late stage drug candidates. The company’s pipeline products comprise HBI-8000, HBI-3000, and HBI-3802. Its HBI-8000 is a novel oral inhibitor of histone deacetylases; HBI-3000 is a channel blocker for the treatment of arrhy …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Theraclion SA (ALTHE):医療機器:M&Aディール及び事業提携情報
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Nordex SE (NDX1)-エネルギー分野:企業M&A・提携分析
    Summary Nordex SE (Nordex) is a manufacturer of wind turbines. Along with its subsidiaries, the company conducts the development, production, servicing and marketing of wind power systems. The service portfolio related to technical planning of wind farm systems ranges from the identification of suit …
  • UNIQA pojistovna, a.s.:企業の戦略・SWOT・財務情報
    UNIQA pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report Summary UNIQA pojistovna, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • OceanaGold Corporation:企業の戦略・SWOT・財務情報
    OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chesnara plc:企業の戦略・SWOT・財務情報
    Chesnara plc - Strategy, SWOT and Corporate Finance Report Summary Chesnara plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hydra Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs. The company’s pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic areas including inflammation, pain, renal, anxiety and pulm …
  • Enerjisa Enerji AS:電力:M&Aディール及び事業提携情報
    Summary Enerjisa Enerji AS (Enerjisa Enerji) is a power generation company. The company operates in the business of distribution, and sale of electricity. It provides electricity wholesale and retail services, marketing, products and services development, energy management, and energy consultancy se …
  • Insys Therapeutics Inc (INSY):企業の財務・戦略的SWOT分析
    Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Abcam Plc (ABC):医療機器:M&Aディール及び事業提携情報
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • KLM Catering Services Schiphol bv:企業の戦略・SWOT・財務分析
    KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report Summary KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Prezzo Ltd:企業の戦略・SWOT・財務情報
    Prezzo Ltd - Strategy, SWOT and Corporate Finance Report Summary Prezzo Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Dohler GmbH:戦略・SWOT・企業財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆